# Methylphenidate in Childhood Apraxia of Speech

> **NCT05185583** · PHASE2 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 18 (actual)

## Conditions studied

- Childhood Apraxia of Speech

## Interventions

- **DRUG:** Methylphenidate Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05185583
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-14
- **Primary completion:** 2025-10-27
- **Final completion:** 2025-10-27
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05185583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05185583, "Methylphenidate in Childhood Apraxia of Speech". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05185583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*